Another schizophrenia treatment

Israel’s Teva has reported positive results of the Phase III trial of its Olanzapine LAI schizophrenia treatment that it has been developing with France’s Medincell. The once-a-month injections met all endpoints. It is likely to be an effective remedy without any serious side effects.

https://en.globes.co.il/en/article-teva-schizophrenia-drug-phase-iii-results-excite-analysts-1001478459

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *